Literature DB >> 19139889

Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma.

Adrian Tempescul1, Jean-Christophe Ianotto, Frederic Morel, Veronique Marion, Marc De Braekeleer, Christian Berthou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19139889     DOI： 10.1007/s00277-008-0692-4

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  3 in total

1.  Late relapsing mantle cell lymphoma showing preserved sensitivity to single-agent lenalidomide.

Authors:  Adrian Tempescul; Jean-Christophe Ianotto; Cristina Bagacean; Pierre-Yves Salaun; Corina Bocsan; Mihnea Zdrenghea
Journal:  Int J Hematol       Date:  2016-05-27       Impact factor: 2.490

2.  Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications.

Authors:  Lan V Pham; Archito T Tamayo; Changping Li; William Bornmann; Waldemar Priebe; Richard J Ford
Journal:  Mol Cancer Ther       Date:  2010-07-06       Impact factor: 6.261

3.  Intestinal mantle cell lymphoma recurring at laparotomy scar region.

Authors:  Amitabh Ray; Ayan Basu; Jyotirup Goswami; Kalyan Bhattacharya
Journal:  Indian J Med Paediatr Oncol       Date:  2009-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.